Today's Most Popular
New Class of Drugs Promising for BRCA-Related Cancers
Drugs called PARP inhibitors may be effective against hereditary cancers caused by BRCA1 and BRCA2 cell mutations.
More Stories in American Cancer Society News
- ACS Researchers: Progress, Challenges in the War on Cancer
- Revised Prostate Cancer Screening Guidelines: What Has--and Hasn't--Changed
- Can Aspirin Reduce the Risk of Breast Cancer Recurrence?
- Prostate Cancer Hormone Therapy May Increase Heart Risk
- Prominent US Radiology Association Says Airport Body Scanners Safe
Other Feedables
Finance - All about the cabbage.
Stock Tips - Feeding your piggy bank.
White Sox Feeds - where you drink your dinner.
Auto Feeds - The auto news drive thru.- Microsoft - All Microsoft News
- more Feedables...